SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-24-000084
Filing Date
2024-05-22
Accepted
2024-05-22 07:08:48
Documents
15
Period of Report
2024-05-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20240522.htm   iXBRL 8-K 31784
2 EX-99.1 rnac_05222024xrmatdesignat.htm EX-99.1 14725
6 image_0.jpg GRAPHIC 113743
  Complete submission text file 0001453687-24-000084.txt   335201

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240522.xsd EX-101.SCH 1981
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240522_lab.xml EX-101.LAB 22788
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240522_pre.xml EX-101.PRE 13107
18 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240522_htm.xml XML 2728
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 24971632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)